Table 1.
Baseline T0 | Intervention | Intervention end | Follow-up | Follow-up | ||
---|---|---|---|---|---|---|
Assessment | Recruitment | (Week 0) | period | T1 | period | end T2 |
(Week 0–12) | (Week 12) | (Week 12–16) | (Week 16) | |||
M-EDL | √ | √ | √ | |||
PDQ-39 | √ | √ | √ | |||
WOQ-9 | √ | √ | √ | |||
FOGQ | √ | √ | √ | |||
CSI | √ | √ | √ | |||
nM-EDL | √ | √ | √ | |||
ADL | √ | √ | √ | √ | ||
MFS | √ | √ | √ | |||
Adverse events | √ | √ |
“√” means the outcomes will be evaluated in this period. M-EDL, Motor Experiences of Daily Living; PDQ-39, 39-item Parkinson's disease Questionnaire; WOQ-9, The 9-item Wearing-Off Questionnaire; FOGQ, Freezing of Gait Questionnaire; CSI, Caregiver Strain Index; nM-EDL, Non-motor Experiences of Daily Living; ADL, Activities of Daily Living; MFS, Morse Fall Scale.